期刊文献+

非血液系统恶性肿瘤与肾病综合征25例临床病理分析 被引量:4

A clinicopathological analysis of non-heamatological malignancy in nephrotic syndrome
原文传递
导出
摘要 目的分析表现有肾病综合征(NS)的非血液系统恶性肿瘤肾脏病变的临床病理特征、实验室检查特点及预后。方法回顾性分析经组织病理学确诊前后出现NS的非血液系统恶性肿瘤25例。结果男20例,女5例,年龄16—83(56.6±17.7)岁。92%的患者肿瘤和NS发生于1年之内。肿瘤分布广泛,其中消化系统和呼吸系统肿瘤占36%和20%。40%以NS为首发症状,合并血尿者为67%,12%于治疗前后合并急性肾衰竭。50%血γ球蛋白升高,28%存在与肾功能不相匹配的贫血。膜性。肾病(MN)为主要的肾脏病理改变,占67%(6/9例)。NS的预后与肿瘤的治疗直接相关,手术治疗和(或)化疗后,部分患者在糖皮质激素辅助治疗下,NS均获缓解;未对肿瘤进行处理者,5例无1例缓解。患者的预后主要与肿瘤有关,只有1例死于肾衰竭。结论恶性肿瘤可以NS为首发症状;年长的Ns患者,尤其以MN为病理表现、同时存在贫血、高1球蛋白血症者,应常规并定期作多部位肿瘤筛查。 Objective To analysis the clinical and pathological features, results of laboratory tests and prognosis of nephrotic syndrome (NS) in patients with non-heamatological malignancy. Methods The data were collected from 25 patients who presented with NS around the diagnosis of non-heamatological malignancy. Results Twenty-five cases were investigated (age: (56.6 ± 17.7) years; male/female ratio: 20/5). Malignancy and NS occurred within one year in 92% patients. There was a wide distribution of malignancy with involvement of 36% in digestive system and 20% in respiratory system. Ten patients (40%) presented with NS as their initial manifestation. Heamaturia appeared in 67% patients and acute renal insufficiency was complicated in 12% cases before treatments. Some other non-specific laboratory tests were found including elevated serum gamma-globulin in 50% and anemia not related with renal failure in 28% cases. Membranous nephropathy was the most common pathological changes in 67% cases. Although NS still continued for several weeks in 8 of 9 cases after surgery and/or chemical therapy, glucoeorticoids was helpful to achieve the remission in these patients. However, no remission was achieved in patients without the treatment for malignancy. Conclusion Malignancy may present with NS as its initial manifestation. It should be inspected routinely and regularly in elder patients with NS, especially in those with membranous nephropathy, as well as gamma-globulinemia and anemia.
出处 《中华内科杂志》 CAS CSCD 北大核心 2008年第11期897-900,共4页 Chinese Journal of Internal Medicine
关键词 肾病综合征 肿瘤 肾小球肾炎 膜性 Nephrotic syndrome Neoplasm Glomerulonephritis, membranous
  • 相关文献

参考文献11

  • 1Fervenza FC, Cosio FG, Erickson SB, et al. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int, 2008, 73: 117-125.
  • 2Lee JC, Yamauchi H, Hopper J Jr. The association of cancer and the nephrotic syndrome. Ann Intern Med, 1966, 64: 41-51.
  • 3Lefaucheur C, Stengel B, Nochy D, et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int, 2006, 70: 1510- 1517.
  • 4Kapoulas S, Liakos S, Karkavelas G, et al. Membranous glomerulonephritis associated with renal cell carcinoma. Clin Nephrol, 2004, 62 : 476-477.
  • 5Rihova Z, Honsova E, Merta M, et al. Secondary membranous nephropathy -one center experience. Ren Fail, 2005, 27: 397 -402.
  • 6Paydas S, Soydas B, Paydas S, et al. Different glomerulopathies accompanying non-small-cell lung cancer. Mt Sinai J Med, 2005, 72 : 279-281.
  • 7Loi S, Perry GJ, Standish H, et al. Glomerulosclerosis: a paraneoplastic phenomenon? Nephrology, 2004, 9:387-391.
  • 8Davison AM. Renal diseases associated with malignancies. Nephrol Dial Transplant, 2001, 16 ( suppl 6 ) : 13-14.
  • 9Stevens PE, Rainford DJ. Nephrotic syndrome as the marker for underlying malignancy. J R Soc Med, 1988, 81: 416-417.
  • 10Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant, 2004, 19 : 574-579.

同被引文献19

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部